Investigating mechanisms of bladder tumorigenesis and therapeutic resistance

Overview

Bladder cancer is the ninth most common malignancy globally, with over 600,000 new cases and 220,000 deaths reported in 2022. Despite recent therapeutic advances, treatment resistance remains a major challenge, contributing to persistently high mortality rates. The overarching goal of our laboratory is to elucidate…